Science Explorer Interactive view Map
Research facility · Tokyo · Japan

Okinaka Memorial Adult Disease Research Institute

okiken.tokyoROR OpenAlex
Research works
39
▲ 272% vs 2013–17
Citations
538
13.8 per fractional work
Top-10% rate
13.1%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Okinaka Memorial Adult Disease Research Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.54× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.33× its world share, 0 worksImmunology and Micro…Computer Science: 0.11× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.19× its world share, 0 worksMaterials ScienceHealth Professions: 0.51× its world share, 0 worksHealth ProfessionsMedicine: 4.48× its world share, 11 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.5×. Every wedge is a field page.

Which keywords describe research at Okinaka Memorial Adult Disease Research Institute?

By fractional works in all years, weighted toward what it does more of than the world: Treatment, Diagnosis, Clinical Practice Guidelines, Hepatocellular Carcinoma, Prognostic Factors, Management, Liver Cancer and Radiofrequency Ablation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Treatment4▲ 8.4×11 topics
  2. Diagnosis4▲ 10×10 topics
  3. Clinical Practice Guidelines4▲ 17×5 topics
  4. Epidemiology4▲ 2.4×16 topics
  5. Hepatocellular Carcinoma3▲ 39×3 topics
  6. Management3▲ 9.9×4 topics
  7. Prognostic Factors3▲ 17×11 topics
  8. Liver Cancer3▲ 128×1 topic
  9. Radiofrequency Ablation3▲ 60×1 topic
  10. Immunotherapy2▲ 10.0×13 topics
  11. Inflammation2▲ 2.6×15 topics
  12. Surgical Management2▲ 12×5 topics
  13. Chemotherapy2▲ 7.6×11 topics
  14. Cardiovascular Disease2▲ 4.0×6 topics
  15. Cholangiocarcinoma2▲ 50×2 topics
  16. Genetic Mutations2▲ 7.3×6 topics
  17. Cancer1▲ 2.5×8 topics
  18. Genetic Variants1▲ 16×4 topics
  19. Hematopoietic Stem Cells1▲ 35×3 topics
  20. Metastasis1▲ 11×7 topics
  21. Oxidative Stress1▲ 1.99×8 topics
  22. Tumor Microenvironment1▲ 10×5 topics
  23. Type 1 Diabetes1▲ 38×2 topics
  24. Insulin Resistance1▲ 6.8×4 topics
  25. Parathyroid Hormone1▲ 30×3 topics
  26. Complications1▲ 5.7×4 topics
  27. Ion Channels1▲ 13×2 topics
  28. Metabolic Syndrome1▲ 3.2×5 topics
  29. Neoadjuvant Therapy1▲ 13×3 topics
  30. PET Imaging1▲ 12×3 topics
  31. Biliary Tract Cancer1▲ 74×1 topic
  32. Intrahepatic Cholangiocarcinoma1▲ 74×1 topic
  33. Laparoscopic Surgery1▲ 24×2 topics
  34. Newborn Screening1▲ 23×2 topics
  35. Postoperative Complications1▲ 19×3 topics
  36. Prognosis1▲ 8.3×5 topics
  37. Therapeutic Strategies1▲ 30×2 topics

Which research topics does Okinaka Memorial Adult Disease Research Institute publish most on?

By volume in 2022–2025: Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Polyomavirus and related diseases and Esophageal and GI Pathology.

Hepatocellular Carcinoma Treatment and Prognosis: 1 fractional worksCholangiocarcinoma and Gallbladder Cancer Studies: 0 fractional worksPolyomavirus and related diseases: 0 fractional worksEsophageal and GI Pathology: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksAcute Lymphoblastic Leukemia research: 0 fractional worksGastrointestinal Tumor R…0Gastrointestinal Tumor Research and Treatment: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksDiabetes and associated disorders: 0 fractional worksOrgan Transplantation Te…0Organ Transplantation Techniques and Outcomes: 0 fractional works
HepatologySurgeryOncologyEpidemiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 1 works
  2. 2 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
  3. 3 Polyomavirus and related diseases Oncology 0 works
  4. 4 Esophageal and GI Pathology Surgery 0 works
  5. 5 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  6. 6 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
  7. 7 Gastrointestinal Tumor Research and Treatment Gastroenterology 0 works
  8. 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
  9. 9 Diabetes and associated disorders Genetics 0 works
  10. 10 Organ Transplantation Techniques and Outcomes Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.0%not open66.0%

World: 28% of research is openly available.

with international co-authors7.2%domestic only92.8%

World: 19% is written across borders.

How has Okinaka Memorial Adult Disease Research Institute's research output changed?

Output in 2018–2022 was 272% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.